Case Studies

Development and refinement of payer value messages for a novel urology treatment

26/04/2023

Author:

Sarah Bailey
About the Author

Article Tags

Early Payer Dialogue HTA HTA Process Launch Pricing

Share this article

Related articles

Articles
06.05.2026
Playing the Long Game: How Early Scientific Advice...

Early HTA scientific advice reduces price and reimbursement risk by informing ev...

Read more
Articles
13.04.2026
Don’t Wait for a JSC: Unlocking Value Through H...

While missing an EU Joint Scientific Consultation (JSC) is suboptimal, the greater strategic concern...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch